Yuhei Shibata

528 total citations
36 papers, 336 citations indexed

About

Yuhei Shibata is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Yuhei Shibata has authored 36 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 6 papers in Surgery. Recurrent topics in Yuhei Shibata's work include Lymphoma Diagnosis and Treatment (10 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Viral-associated cancers and disorders (5 papers). Yuhei Shibata is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Viral-associated cancers and disorders (5 papers). Yuhei Shibata collaborates with scholars based in Japan. Yuhei Shibata's co-authors include Nobuhiko Nakamura, Hisashi Tsurumi, Masahito Shimizu, Takeshi Hara, Junichi Kitagawa, Takuro Matsumoto, Naoe Goto, Hiroshi Nakamura, Nobuhiro Kanemura and Tamotsu Takeuchi and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Yuhei Shibata

33 papers receiving 334 citations

Peers

Yuhei Shibata
Nicole Engel Germany
Pallavi Khattar United States
Basel M. Touban United States
Lisa Ehlers Germany
Yeqi Nian China
Jyoti Joshi Mundra United States
Pedram Daraei United States
Nicole Engel Germany
Yuhei Shibata
Citations per year, relative to Yuhei Shibata Yuhei Shibata (= 1×) peers Nicole Engel

Countries citing papers authored by Yuhei Shibata

Since Specialization
Citations

This map shows the geographic impact of Yuhei Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhei Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhei Shibata more than expected).

Fields of papers citing papers by Yuhei Shibata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuhei Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhei Shibata. The network helps show where Yuhei Shibata may publish in the future.

Co-authorship network of co-authors of Yuhei Shibata

This figure shows the co-authorship network connecting the top 25 collaborators of Yuhei Shibata. A scholar is included among the top collaborators of Yuhei Shibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuhei Shibata. Yuhei Shibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Nobuhiko, Nobuhiro Kanemura, Takuro Matsumoto, et al.. (2024). Effect of Vitamin D and Skeletal Muscle Mass on Prognosis of Patients with Diffuse Large B-Cell Lymphoma. Nutrients. 16(16). 2653–2653.
3.
Kanemura, Nobuhiro, Nobuhiko Nakamura, Yuhei Shibata, et al.. (2023). The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 65(3). 339–345. 4 indexed citations
4.
Shibata, Yuhei, et al.. (2023). Werner syndrome associated with poorly differentiated thyroid carcinoma and systemic sclerosis-like skin manifestations: A case report. Modern Rheumatology Case Reports. 8(1). 95–100. 1 indexed citations
5.
Nakamura, Nobuhiko, Nobuhiro Kanemura, Takuro Matsumoto, et al.. (2023). Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population. Scientific Reports. 13(1). 19060–19060. 2 indexed citations
6.
Nakamura, Nobuhiko, Junichi Kitagawa, Takao Miwa, et al.. (2023). A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non‐Hodgkin lymphoma. Hematological Oncology. 42(1). e3236–e3236. 1 indexed citations
7.
Wada, Haruka, Yuhei Shibata, Ryo Otsuka, et al.. (2019). Flow cytometric identification and cell-line establishment of macrophages in naked mole-rats. Scientific Reports. 9(1). 17981–17981. 11 indexed citations
8.
Shibata, Yuhei, Midori Soda, Miho Yamamoto, et al.. (2019). Evaluation of the effectiveness of caspofungin against febrile neutropenia and the factors related to the alteration in its plasma concentration. Journal of Infection and Chemotherapy. 25(10). 801–805. 1 indexed citations
9.
Yamamoto, Yasuko, Naoe Goto, Masao Takemura, et al.. (2017). Association between increased serum GP88 (progranulin) concentrations and prognosis in patients with malignant lymphomas. Clinica Chimica Acta. 473. 139–146. 23 indexed citations
10.
Hayashi, Hiroko, Akio Suzuki, Masashi Ishihara, et al.. (2017). Control of Constipation in Patients Receiving CHOP or CHOP-Like Chemotherapy Regimens for Non-Hodgkin’s Lymphoma. Biological and Pharmaceutical Bulletin. 40(5). 698–702. 8 indexed citations
11.
Matsumoto, Takuro, Atsushi Suetsugu, Miki Nakamura, et al.. (2016). A Mouse Model of Fluorescent Protein-expressing Disseminated Peritoneal Lymphoma for Fluorescence-guided Surgery. Anticancer Research. 36(9). 4483–4488. 2 indexed citations
12.
Nakamura, Hiroyuki, Yuhei Shibata, & Tsuyoshi Takeda. (2016). Sternoclavicular Joint Swelling in a Patient with Rheumatoid Arthritis. The Journal of Rheumatology. 43(11). 2074–2075. 2 indexed citations
13.
Shibata, Yuhei, Takeshi Hara, Junji Nagano, et al.. (2016). The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis. PLoS ONE. 11(1). e0146279–e0146279. 21 indexed citations
14.
Kitagawa, Junichi, Yuhei Shibata, Takuro Matsumoto, et al.. (2016). Efficacy and safety of denosumab in multiple myeloma.. PubMed. 57(5). 592–6.
15.
Kitagawa, Junichi, Takuro Matsumoto, Yuhei Shibata, et al.. (2015). Efficacy and safety of denosumab for multiple myeloma. Annals of Oncology. 26. vii85–vii85. 1 indexed citations
16.
Nakamura, Nobuhiko, Takeshi Hara, Yuhei Shibata, et al.. (2015). Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma. Annals of Hematology. 94(12). 2043–2053. 79 indexed citations
17.
Nakamura, Nobuhiko, Takuro Matsumoto, Yuhei Shibata, et al.. (2015). Sarcopenia and adipopenia are independent prognostic factors in patients with acute myeloid leukemia. Annals of Oncology. 26. vii84–vii84. 1 indexed citations
18.
Hara, Takeshi, Takuro Matsumoto, Yuhei Shibata, et al.. (2015). High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia. Leukemia & lymphoma. 57(1). 92–98. 34 indexed citations
19.
Fukuno, Kenji, Takeshi Hara, Hisashi Tsurumi, et al.. (2014). Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics. Leukemia & lymphoma. 56(5). 1398–1405. 35 indexed citations
20.
Goto, Naoe, Hisashi Tsurumi, Masao Takemura, et al.. (2014). Serum Soluble Tumor Necrosis Factor Receptor 1 Level is Associated with the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with the CHOP or R-CHOP Regimen. Journal of Clinical and Experimental Hematopathology. 54(2). 117–127. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026